Thomas Jefferson U researchers find that in mice normal cells can be protected by an anti-cancer drug

An anti-cancer drug protects normal cells from radiation damage and increases the effectiveness of radiation therapy in prostate cancer mouse models. Click here to read the full press release. ### Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are … Continue reading “Thomas Jefferson U researchers find that in mice normal cells can be protected by an anti-cancer drug”

An anti-cancer drug protects normal cells from radiation damage and increases the effectiveness of radiation therapy in prostate cancer mouse models.

Click here to read the full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply